Jan 2026: Mitsubishi Corporation Life Sciences enhanced R&D collaborations to develop high-purity glutathione for medical and d!etary supplement use
Thats why continuing healthy habits, or sometimes staying on the lowest effective dose of medication, makes long-term success more likely
Llewellyn-Smith IJ, Marina N, Manton RN, Reimann F, Gribble FM, Trapp S
As supply began to normalize, FDA resolved the tirzepatide shortage in December 2024 and the semaglutide shortage in February 2025, and provided phased enforcement grace periods for compounders to wind down operations
These results suggest that PYY can directly activate PPRE in colonic epithelium, as evidenced by the upregulation of PPRE downstream genes and the increased ATP production following PYY treatment (Fig